Antidepressant Cymbalta FDA Approved for Back Pain
Links shared publicly online about this topic.
- 586total visits
Antidepressant Cymbalta FDA Approved for Back Pain
View full resource at fyiliving.com
Tags: Pain, Back Pain, Anxiety Medication, Antidepressant, Fibromyalgia Medication, Neuropathic Pain Medication, FDA, Cymbalta
Most Recently Shared on January 12, 2011 at 5:11 pm By:
FDA Approves Antidepressant Cymbalta for Back Pain ---> http://dld.bz/Frsz
Cymbalta for Musculoskeletal Pain
hcplive.com — “The FDA approved Cymbalta to treat chronic musculoskeletal pain, including discomfort from osteoarthritis and chronic lower back pain.” View full resource at hcplive.com
Most Recently Shared on November 8, 2010 at 9:38 pm By:
FDA Clears Cymbalta to Treat Chronic Lower Back Pain, Osteoarthritis - AOL Health
aolhealth.com — “The antidepressant Cymbalta has gotten the go-ahead to be prescribed for persistent back pain and osteoarthritis, the Food and Drug Administration sai” View full resource at aolhealth.com
Most Recently Shared on November 8, 2010 at 7:45 pm By:
New treatments for chronic pain relief and osteoarthritis hit the market. http://aol.it/9IgCfK #fda #cymbalta #pain #osteoarthritis
Medical News: Antidepressant Gets Nod for Treatment of Back Pain - in Pain Management, Pain Management from MedPage Today
medpagetoday.com — “WASHINGTON -- The FDA has approved duloxetine hydrochloride (Cymbalta), an antidepressant, to treat chronic back pain and osteoarthritis pain.” View full resource at medpagetoday.com
Most Recently Shared on November 6, 2010 at 7:32 pm By:
Antidepressant Cymbalta Gets Nod for Treatment of Back Pain - from MedPage Today http://t.co/s9riDFz via @AddThis
FDA: Anti-depressant Cymbalta can also relieve back pain
nydailynews.com — “The drug is also approved to treat depression, anxiety, diabetes-related pain and fiomyalgia.” View full resource at nydailynews.com
Most Recently Shared on November 5, 2010 at 7:10 pm By:
FDA: Anti-depressant Cymbalta can also relieve back pain http://bit.ly/9pP0nk
FDA Approves Cymbalta to be Marketed for Chronic Lower Back Pain - Pharma Marketing Network Forums
forums.pharma-mkting.com — “FDA Approves Cymbalta to be Marketed for Chronic Lower Back Pain Industry News” View full resource at forums.pharma-mkting.com
Most Recently Shared on November 5, 2010 at 4:25 pm By:
FDA Approves Cymbalta to be Marketed for Chronic Lower Back Pain. http://bit.ly/aSM7B7 Can't wait to see the TV ads!
FDA Approves Cymbalta for Chronic Musculoskeletal Pain
webmd.com — “A drug used to treat depression, anxiety, fibromyalgia, and diabetic neuropathy has been approved by the FDA for a new use -- to treat chronic musculoskeletal pain, including pain caused by osteoarthritis and chronic low back pain.” View full resource at webmd.com
Most Recently Shared on November 5, 2010 at 2:17 pm By:
FDA Approves Cymbalta for Chronic Musculoskeletal Pain http://bit.ly/9pH0fw
Eli Lilly's Cymbalta gets FDA nod for pain | Reuters
reuters.com — “NEW YORK (Reuters) - Eli Lilly said on Thursday U.S. regulators approved the use of Cymbalta, its blockbuster anti-depressant drug, for chronic musculoskeletal pain, including lower back pain and osteoarthritis.The” View full resource at reuters.com
Most Recently Shared on November 5, 2010 at 3:30 am By:
Eli Lilly's Cymbalta gets FDA nod for pain: NEW YORK (Reuters) - Eli Lilly said on Thursday U.S. regulator... http://tinyurl.com/27cxlnk
Eli Lilly's Cymbalta gets FDA nod for pain | Reuters
reuters.com — “NEW YORK (Reuters) - Eli Lilly said on Thursday U.S. regulators approved the use of Cymbalta, its blockbuster anti-depressant drug, for chronic musculoskeletal pain, including lower back pain and osteoarthritis. The” View full resource at reuters.com
Most Recently Shared on November 5, 2010 at 3:00 am By:
Eli Lilly's Cymbalta gets FDA nod for pain http://dlvr.it/82yDg
Medical News: Antidepressant Gets Nod for Treatment of Back Pain - in Pain Management, Pain Management from MedPage Today
medpagetoday.com — “WASHINGTON -- The FDA has approved duloxetine hydrochloride (Cymbalta), an antidepressant, to treat chronic back pain and osteoarthritis pain.” View full resource at medpagetoday.com
Most Recently Shared on November 4, 2010 at 11:51 pm By:
Antidepressant Gets Nod for Treatment of Back Pain: WASHINGTON (MedPage Today) -- The FDA has approved duloxetin... http://bit.ly/bBtlfd
FDA Advisory Panel Recommends Cymbalta for Use to Treat Chronic Pain
spine-health.com — “Read what conditions the FDA advisory panel recommends for Cymbalta to treat.” View full resource at spine-health.com
Most Recently Shared on August 26, 2010 at 12:57 am By:
FDA Advisory Panel Recommends Cymbalta for Use to Treat Chronic Pain http://bit.ly/cuD8sU
Cymbalta: FDA panel gives a qualified nod to antidepressant for chronic pain - latimes.com
latimes.com — “A government advisory panel says the FDA should allow marketing of the antidepressant Cymbalta for a wider range of pain, including chronic back pain.” View full resource at latimes.com
Most Recently Shared on August 21, 2010 at 6:49 pm By:
FDA panel gives a qualified nod to antidepressant for chronic pain - http://bit.ly/ca8sQ7 << to "include those with chronic back pain"
UPDATE 2-FDA panel backs wider use of Eli Lilly's Cymbalta | Reuters
reuters.com — “* Eli Lilly's Cymbalta OK'd for chronic pain -FDA panel * Panelists split over back pain, arthritis use * Drugmaker seeking FDA approval to promote new use * FDA deadline passed, decision could come” View full resource at reuters.com
Most Recently Shared on August 20, 2010 at 3:59 pm By:
FDA panel supports Cymbalta for back pain, but not osteoarthritis http://www.reuters.com/article/idUSN1925181020100819 http://fb.me/FZGJbQkQ
FDA panel backs wider use of antidepressant | Lifescript.com
lifescript.com — “BETHESDA, Md. (Reuters) - Eli Lilly and Co's antidepressant Cymbalta should be approved to help...” View full resource at lifescript.com
Most Recently Shared on August 20, 2010 at 1:56 pm By:
FDA panel backs wider use of antidepressant http://bit.ly/aOUmbF
Cymbalta (Duloxetine HCl) Approved By FDA Advisory Committee For Expanded Pain Indications - QualityPoint Technologies
qualitypointtech.net — “The Anesthetic and Life Support Drugs Advisory Committee which advises the FDA on whether to approve new drugs or alter their indications, has voted 8-6 in favor of expanding pain indications for Cymbalta (duloxetine HCl). The Committee's decision is not final - the FDA has to decide - however, the FDA usually goes along with what the Committee recommends. The Advisory Committee recommended the expanded use of Cymbalta for the treatment of chronic knee and lower back pain...” View full resource at qualitypointtech.net
Most Recently Shared on August 20, 2010 at 1:18 pm By:
Cymbalta (Duloxetine HCl) Approved By FDA Advisory Committee For Expanded Pain Indications: The Anesthetic and Lif... http://bit.ly/cEcF29
Advertisement

